Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Selling General And Administration | 246,672 | 51,323 | 59,340 | 182,443 | 177,632 | -- |
| General And Administrative Expense | 246,672 | 51,323 | 59,340 | 182,443 | 177,632 | -- |
| Other Operating Expenses | 89,765 | 31,019 | 27,987 | 107,103 | 111,689 | -- |
| Operating Expense | 336,437 | 82,342 | 87,327 | 289,546 | 289,321 | -- |
| Operating Income | -336,437 | -82,342 | -87,327 | -289,546 | -289,321 | -- |
| EBIT | -336,437 | -82,342 | -87,327 | -289,546 | -289,321 | -- |
| Other Income Expense | 11,067 | -- | 5,967 | -- | 30,350 | 10,350 |
| Special Income Charges | 0.00 | 0.00 | 0.00 | 20,000 | 20,000 | -- |
| Gain On Sale Of Security | 11,067 | -- | 5,967 | -- | 10,350 | 10,350 |
| Pretax Income | -325,370 | -82,342 | -81,360 | -269,546 | -258,971 | -- |
| Tax Provision | -- | -- | -1,146 | -- | -- | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 84.05 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -325,370 | -82,342 | -80,214 | -269,546 | -258,971 | -- |
| Net Income From Continuing Operation Net Minority Interest | -325,370 | -82,342 | -80,214 | -269,546 | -258,971 | -- |
| Net Income Including Noncontrolling Interests | -267,198 | -63,505 | -80,214 | -269,546 | -258,971 | -- |
| Net Income Common Stockholders | -267,198 | -63,505 | -80,214 | -269,546 | -258,971 | -- |
| Net Income | -267,198 | -63,505 | -80,214 | -269,546 | -258,971 | -- |
| EBITDA | -336,437 | -82,342 | -87,327 | -289,546 | -289,321 | -- |
| Normalized EBITDA | -347,504 | -82,342 | -93,294 | -309,546 | -319,671 | -- |
| Basic EPS | -0.00 | -0.00 | -0.00 | -- | -0.01 | -0.00 |
| Diluted EPS | -0.00 | -0.00 | -0.00 | -- | -0.01 | -0.00 |
| Basic Average Shares | 74.7M | 84.1M | 67.2M | -- | 55.8M | 54.1M |
| Diluted Average Shares | 74.7M | 84.1M | 67.2M | -- | 55.8M | 54.1M |
| Total Unusual Items | 11,067 | 0.00 | 5,967 | 20,000 | 30,350 | -- |
| Total Unusual Items Excluding Goodwill | 11,067 | 0.00 | 5,967 | 20,000 | 30,350 | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | -- |
| Normalized Income | -336,437 | -82,342 | -86,097 | -289,546 | -289,321 | -- |
| Diluted NI Availto Com Stockholders | -267,198 | -63,505 | -80,214 | -269,546 | -258,971 | -- |
| Gain On Sale Of Ppe | 0.00 | 0.00 | 0.00 | 20,000 | 20,000 | -- |
| Net Income Continuous Operations | -325,370 | -82,342 | -80,214 | -269,546 | -258,971 | -- |
| Net Income From Tax Loss Carryforward | 58,172 | 18,837 | -- | -- | 0.00 | 0.00 |
| Other Gand A | 140,129 | 51,323 | 59,340 | 74,250 | 69,439 | -- |
| Salaries And Wages | 106,543 | 0.00 | -- | 108,193 | 108,193 | 108,193 |
| Total Expenses | 336,437 | 82,342 | 87,327 | 289,546 | 289,321 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 674,914 | 652,674 | 184,481 | 342,471 | 21,596 | -- |
| Cash Cash Equivalents And Short Term Investments | 873,298 | 843,428 | 326,896 | 442,824 | 114,121 | -- |
| Cash Equivalents | -- | -- | -- | 0.00 | 0.00 | 10,000 |
| Cash Financial | 674,914 | 652,674 | 184,481 | 342,471 | 21,596 | -- |
| Other Short Term Investments | 198,384 | 190,754 | 142,415 | 100,353 | 92,525 | -- |
| Receivables | 107,739 | 144,502 | 40,417 | 104,234 | 45,763 | -- |
| Prepaid Assets | 50.00 | 50.00 | 50.00 | 50.00 | 1,050 | -- |
| Current Assets | 981,087 | 987,980 | 760,946 | 547,108 | 160,934 | -- |
| Net PPE | 2.2M | 2.0M | 1.5M | 1.7M | 1.7M | -- |
| Total Non Current Assets | 2.2M | 2.0M | 1.5M | 1.7M | 1.7M | -- |
| Total Assets | 3.2M | 3.0M | 2.3M | 2.2M | 1.8M | -- |
| Accounts Payable | 100,401 | 80,690 | 55,848 | 96,807 | 109,905 | -- |
| Payables | 100,401 | 80,690 | 55,848 | 96,807 | 109,905 | -- |
| Payables And Accrued Expenses | 100,401 | 80,690 | 55,848 | 96,807 | 109,905 | -- |
| Other Current Liabilities | -- | 38,189 | 57,026 | 24,839 | -- | -- |
| Current Liabilities | 100,401 | 118,879 | 112,874 | 121,646 | 109,905 | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 100,401 | 118,879 | 112,874 | 121,646 | 109,905 | -- |
| Common Stock | 11.9M | 11.8M | 11.1M | 10.9M | 10.4M | -- |
| Capital Stock | 11.9M | 11.8M | 11.1M | 10.9M | 10.4M | -- |
| Additional Paid In Capital | 1.9M | 1.7M | 1.7M | 1.7M | 1.8M | -- |
| Retained Earnings | -10.5M | -10.3M | -10.3M | -10.2M | -10.1M | -- |
| Gains Losses Not Affecting Retained Earnings | -253,622 | -256,152 | -304,491 | -301,653 | -311,231 | -- |
| Other Equity Adjustments | -253,622 | -256,152 | -304,491 | -301,653 | -311,231 | -- |
| Common Stock Equity | 3.1M | 2.9M | 2.2M | 2.1M | 1.7M | -- |
| Stockholders Equity | 3.1M | 2.9M | 2.2M | 2.1M | 1.7M | -- |
| Total Equity Gross Minority Interest | 3.1M | 2.9M | 2.2M | 2.1M | 1.7M | -- |
| Total Capitalization | 3.1M | 2.9M | 2.2M | 2.1M | 1.7M | -- |
| Net Tangible Assets | 3.1M | 2.9M | 2.2M | 2.1M | 1.7M | -- |
| Tangible Book Value | 3.1M | 2.9M | 2.2M | 2.1M | 1.7M | -- |
| Working Capital | 880,686 | 869,101 | 648,072 | 425,462 | 51,029 | -- |
| Invested Capital | 3.1M | 2.9M | 2.2M | 2.1M | 1.7M | -- |
| Share Issued | 88.5M | 84.1M | 70.3M | 66.9M | 59.1M | -- |
| Ordinary Shares Number | 88.5M | 84.1M | 70.3M | 66.9M | 59.1M | -- |
| Other Receivables | -- | 92,000 | -- | 58,500 | -- | -- |
| Restricted Cash | -- | -- | 393,583 | -- | -- | -- |
| Taxes Receivable | 107,739 | 52,502 | 40,417 | 45,734 | 45,763 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1,639 | -161,584 | -64,470 | -152,728 | -65,894 | -- |
| Cash Flow From Continuing Operating Activities | -1,639 | -161,584 | -64,470 | -152,728 | -65,894 | -- |
| Stock Based Compensation | 106,543 | -- | -- | 0.00 | 0.00 | -- |
| Change In Working Capital | 58,586 | -79,242 | 22,857 | -79,747 | -13,138 | -- |
| Change In Receivables | -- | -- | 63,817 | 29.00 | -30,429 | -4,686 |
| Change In Payables And Accrued Expense | -- | -- | -40,960 | -80,775 | 18,291 | 37,879 |
| Change In Payable | -- | -- | -40,960 | -80,775 | 18,291 | 37,879 |
| Other Non Cash Items | -38,189 | -18,837 | -1,146 | -- | -- | -- |
| Capital Expenditure | -234,741 | -158,065 | -11,004 | -- | -- | -232,883 |
| Purchase Of PPE | -234,741 | -158,065 | -11,004 | 65,141 | 15,336 | -- |
| Net PPE Purchase And Sale | -234,741 | -158,065 | 88,996 | 85,141 | 15,336 | -- |
| Sale Of Investment | -8,780 | 0.00 | 11,067 | 3,728 | 150.00 | -- |
| Net Investment Purchase And Sale | -8,780 | 0.00 | 11,067 | 3,728 | 150.00 | -- |
| Investing Cash Flow | 70,396 | -158,066 | 100,064 | 88,869 | 15,486 | -- |
| Cash Flow From Continuing Investing Activities | -243,521 | -158,065 | 100,063 | 88,869 | 15,486 | -- |
| Issuance Of Capital Stock | 267,400 | 394,599 | 200,000 | 389,950 | 0.00 | -- |
| Net Common Stock Issuance | 267,400 | 394,599 | 200,000 | 389,950 | 0.00 | -- |
| Financing Cash Flow | 267,400 | 394,259 | 200,000 | 384,735 | 0.00 | -- |
| Cash Flow From Continuing Financing Activities | 267,400 | 394,259 | 200,000 | 384,735 | 0.00 | -- |
| Changes In Cash | 22,240 | 74,610 | 235,593 | 320,875 | -50,407 | -- |
| Beginning Cash Position | 652,674 | 578,064 | 342,471 | 21,596 | 72,003 | -- |
| End Cash Position | 674,914 | 652,674 | 578,064 | 342,471 | 21,596 | -- |
| Free Cash Flow | -236,380 | -319,649 | -75,474 | -87,587 | -50,558 | -- |
| Change In Account Payable | -- | -- | -40,960 | -73,411 | 10,926 | 37,879 |
| Change In Prepaid Assets | -- | -- | -- | -- | -1,000 | 0.00 |
| Common Stock Issuance | 267,400 | 394,599 | 200,000 | 389,950 | 0.00 | -- |
| Gain Loss On Investment Securities | -5,100 | 0.00 | -5,967 | -- | 0.00 | -- |
| Gain Loss On Sale Of PPE | -- | -- | -- | -20,000 | 0.00 | -- |
| Net Income From Continuing Operations | -123,479 | -63,505 | -80,214 | -63,331 | -52,756 | -- |
| Net Other Financing Charges | 0.00 | -- | -- | -5,215 | 0.00 | -- |
| Net Other Investing Changes | -- | -- | 1.00 | -- | -- | -- |
| Operating Gains Losses | -5,100 | 0.00 | -5,967 | -9,650 | 0.00 | -- |
| Sale Of PPE | 0.00 | 0.00 | 100,000 | 20,000 | 0.00 | -- |